SOLLINI, Martina
 Distribuzione geografica
Continente #
NA - Nord America 4.918
AS - Asia 2.884
EU - Europa 1.093
SA - Sud America 525
Continente sconosciuto - Info sul continente non disponibili 145
AF - Africa 130
OC - Oceania 8
Totale 9.703
Nazione #
US - Stati Uniti d'America 4.742
SG - Singapore 1.682
CN - Cina 545
BR - Brasile 425
VN - Vietnam 289
IT - Italia 275
FI - Finlandia 176
IE - Irlanda 136
DE - Germania 112
CA - Canada 100
GB - Regno Unito 80
IN - India 77
SE - Svezia 67
HK - Hong Kong 64
NG - Nigeria 63
FR - Francia 56
AR - Argentina 46
NL - Olanda 38
RU - Federazione Russa 37
BD - Bangladesh 33
MX - Messico 28
IQ - Iraq 27
ES - Italia 20
TR - Turchia 18
IL - Israele 17
PL - Polonia 17
ZA - Sudafrica 14
BE - Belgio 13
CL - Cile 13
JP - Giappone 13
UA - Ucraina 13
CO - Colombia 11
ID - Indonesia 11
IR - Iran 11
AT - Austria 10
EC - Ecuador 10
PK - Pakistan 10
UZ - Uzbekistan 10
TN - Tunisia 9
VE - Venezuela 9
CR - Costa Rica 8
EU - Europa 8
JM - Giamaica 8
LT - Lituania 8
PH - Filippine 8
SA - Arabia Saudita 8
KG - Kirghizistan 7
MY - Malesia 7
SC - Seychelles 7
TT - Trinidad e Tobago 7
AU - Australia 6
DZ - Algeria 6
EG - Egitto 6
ET - Etiopia 6
GT - Guatemala 6
KZ - Kazakistan 6
MA - Marocco 6
EE - Estonia 5
JO - Giordania 5
KE - Kenya 5
NI - Nicaragua 5
PE - Perù 5
AZ - Azerbaigian 4
CH - Svizzera 4
HR - Croazia 4
NP - Nepal 4
OM - Oman 4
PT - Portogallo 4
RO - Romania 4
SN - Senegal 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
HN - Honduras 3
KR - Corea 3
LB - Libano 3
PA - Panama 3
PY - Paraguay 3
RS - Serbia 3
SY - Repubblica araba siriana 3
MD - Moldavia 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
TH - Thailandia 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
GR - Grecia 1
HU - Ungheria 1
IS - Islanda 1
KW - Kuwait 1
LC - Santa Lucia 1
Totale 9.558
Città #
Singapore 739
Ashburn 566
San Jose 421
Chandler 280
The Dalles 240
Wilmington 226
Shanghai 216
Dallas 206
Helsinki 175
Beijing 170
New York 150
San Mateo 147
Council Bluffs 137
Dublin 135
Boardman 123
Ho Chi Minh City 110
Milan 105
Santa Clara 93
Ann Arbor 91
Los Angeles 83
Benin City 63
Princeton 62
Lawrence 60
Hong Kong 57
Hanoi 56
Pune 42
Leawood 41
London 39
Phoenix 35
Rome 35
Amsterdam 34
São Paulo 34
Toronto 33
Buffalo 31
Fairfield 28
North Bergen 28
Paris 28
Seattle 28
Brooklyn 27
Da Nang 25
Woodbridge 23
Monmouth Junction 21
Montreal 20
Haiphong 19
Chicago 17
Atlanta 16
Boston 16
Rio de Janeiro 16
Warsaw 16
Belo Horizonte 15
Orem 14
Brussels 13
Florence 13
Naples 13
Redwood City 13
San Diego 13
Baghdad 12
Jacksonville 12
San Francisco 12
Cincinnati 11
Falkenstein 11
Johannesburg 11
Manchester 11
Stockholm 11
Brasília 10
Charlotte 10
Miami 10
Moscow 10
Munich 10
Norwalk 10
Pittsburgh 10
Tashkent 10
Curitiba 9
Figino 9
Houston 9
Mexico City 9
Porto Alegre 9
Tokyo 9
Washington 9
Campinas 8
Denver 8
Newark 8
Santiago 8
Calgary 7
Chennai 7
Des Moines 7
Detroit 7
Kocaeli 7
Philadelphia 7
Zhengzhou 7
Bishkek 6
Queens 6
Redmond 6
Reston 6
Sorocaba 6
Turin 6
Vienna 6
Addis Ababa 5
Biên Hòa 5
Düsseldorf 5
Totale 5.829
Nome #
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma 142
A virtual biopsy of liver parenchyma to predict the outcome of liver resection 138
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 138
[F-18] FDG PET/CT features for the molecular characterization of primary breast tumors 137
Applications of PET imaging with radiolabelled choline (C-11/F-18-choline) 135
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis 122
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery 117
[18F]FDG-PET/CT Texture Analysis in “Hot” Thyroid Nodules: Results of the validation Cohort 116
[18F]FDG-PET/CT texture analysis in thyroid incidentalomas: preliminary results 115
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 113
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 109
Imaging-Based Prediction of Molecular Therapy Targets in NSCLC by Radiogenomics and AI Approaches: A Systematic Review 109
[F-18]FDG PET/CT in non-union: improving the diagnostic performances by using both PET and CT criteria 107
Climbing the steps of the evidence-based medicine pyramid: highlights from Annals of Nuclear Medicine 2019 106
PET/CT radiomics in breast cancer: Mind the step 105
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 104
[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer 103
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 100
Chemotherapy-Associated Liver Injuries: Unmet Needs and New Insights for Surgical Oncologists 99
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT 97
Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients 97
Radiomics of Liver Metastases: A Systematic Review 97
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 96
Artificial intelligence and hybrid imaging: the best match for personalized medicine in oncology 96
Cardiac molecular pathways influenced by doxorubicin treatment in mice 96
Deep learning in Nuclear Medicine—focus on CNN-based approaches for PET/CT and PET/MR: where do we stand? 96
Texture analysis and machine learning to characterize suspected thyroid nodules and differentiated thyroid cancer: Where do we stand? 94
Hybrid PET/MRI in Infection and Inflammation: An Update About the Latest Available Literature Evidence 92
Personalised PET imaging in oncology: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication 92
Comments on the Italian Society of Endocrinology recommendations on post-surgical thyroid ablation in differentiated thyroid cancer 91
PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology 91
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas 89
Random forest analysis to predict Disease-Free Survival using FDG-PET and CT in Lung Cancer 89
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy 89
Contrast Administration Impacts CT-Based Radiomics of Colorectal Liver Metastases and Non-Tumoral Liver Parenchyma Revealing the "Radiological" Tumour Microenvironment 89
HCC Radioembolization with Yttrium-90 Polymer Beads (SIR-Spheres):Tc-99m-MAA SPECT/CT based dosimetry correlation with survival and tumor response 88
The "3M" Approach to Cardiovascular Infections: Multimodality, Multitracers, and Multidisciplinary 88
FDG PET/CT as theranostic imaging in diagnosis of non-small cell lung cancer 87
Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy 87
Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer 87
[18F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer 87
ALBI grade for outcome prediction in patients affected by hepatocellular carcinoma treated with transarterial radioembolization 85
Quantitative imaging biomarkers in nuclear medicine: from SUV to image mining studies. Highlights from annals of nuclear medicine 2018 85
Interdisciplinarity: An essential requirement for translation of radiomics research into clinical practice -a systematic review focused on thoracic oncology 84
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome 83
Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical Study 83
Methodological framework for radiomics applications in Hodgkin’s lymphoma 82
Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics 81
Alternative Nuclear Imaging Tools for Infection Imaging 80
The five “W”s and “How” of Targeted Alpha Therapy: Why? Who? What? Where? When? and How? 80
Distributed learning: a reliable privacy-preserving strategy to change multicenter collaborations using AI 80
What to Trust, PSA or [68Ga]Ga-PSMA-11: Learn from Experience 80
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 79
State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis 79
Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study 78
18F-FDG and 68Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study 78
Role of Multimodal Imaging in Patients With Suspected Infections After the Bentall Procedure 77
COVID-19 vaccination, implications for PET/CT image interpretation and future perspectives 75
PSMA expression a promising biomarker to predictdifferentiated thyroid cancer aggressiveness and outcome 74
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation 74
PET/MRI in Infection and Inflammation 73
Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma 72
The Development of an Intelligent Agent to Detect and Non-Invasively Characterize Lung Lesions on CT Scans: Ready for the "Real World"? 70
Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy. 70
The Role of PET Imaging in the Differential Diagnosis between Radiation Necrosis and Recurrent Disease in Irradiated Adult-Type Diffuse Gliomas: A Systematic Review 69
Concerns About the Risk of Myeloid Malignancies After Radioiodine Therapy in Thyroid Cancer 69
Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group 68
[(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results 67
Imaging-based representation and stratification of intra-tumor heterogeneity via tree-edit distance 67
The complementary role of PSMA expression and [18F]FDG PET/CT in predicting thyroid cancer outcome: from black and white to shades of gray, in the era of precision oncology 66
Complete remission of follicular lymphoma after SARS-CoV-2 infection: from the "flare phenomenon" to the "abscopal effect" 66
The use of 18F-FDG-PET/CT in the diagnostic workup of CIED infections: another perspective 65
Contrast-Enhanced Mammography versus Breast Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis 65
[18F]FDG-PET/CT texture analysis in thyroid incidentaloma: preliminary results 65
Explainable domain transfer of distant supervised cancer subtyping model via imaging-based rules extraction 64
(18)F-FDG PET/CT versus bone scintigraphy in the follow-up of gastric cancer 64
Imaging Correlates between Headache and Breast Cancer: An [18F]FDG PET Study 64
EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD) 63
PET and PET/CT with 68gallium-labeled somatostatin analogues in Non GEP-NETs Tumors 63
Radiomics of Intrahepatic Cholangiocarcinoma and Peritumoral Tissue Predicts Postoperative Survival: Development of a CT-Based Clinical-Radiomic Model 62
Radiomics of Biliary Tumors: A Systematic Review of Current Evidence 61
Present and future of target therapies and theranostics: refining traditions and exploring new frontiers-highlights from annals of Nuclear Medicine 2021 61
Biomarkers in well differentiated thyroid cancer 61
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 60
Lymphoscintigraphy for the Differential Diagnosis of Peripheral Edema and Intracavitary Lymph Effusion 60
Virtual Biopsy for Diagnosis of Chemotherapy-Associated Liver Injuries and Steatohepatitis: A Combined Radiomic and Clinical Model in Patients with Colorectal Liver Metastases 60
Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas 60
Radioisotope-Guided Excision of Mediastinal Lymph Nodes in Patients with Non-Small Cell Lung Carcinoma: Feasibility and Clinical Impact 60
Image Embeddings Extracted from CNNs Outperform Other Transfer Learning Approaches in Classification of Chest Radiographs 59
Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study 59
Total glycolytic volume and biological markers in mesothelioma patients 58
Recurrence-specific supervised graph clustering for subtyping Hodgkin Lymphoma radiomic phenotypes 56
The role of preoperative [11C]methionine PET in defining tumor-related epilepsy and predicting short-term postoperative seizure control in temporal lobe low-grade gliomas 56
Methodological Aspects of Lymphoscintigraphy: Bicompartmental Versus Monocompartmental Radiocolloid Administration 55
Current Status of Molecular Imaging in Infections 54
PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival 54
Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis 53
Radiomics-Based Inter-Lesion Relation Network to Describe [18F]FMCH PET/CT Imaging Phenotypes in Prostate Cancer 52
Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art 51
ED-B-Containing Isoform of Fibronectin in Tumor Microenvironment of Thymomas: A Target for a Theragnostic Approach 51
Totale 8.220
Categoria #
all - tutte 61.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022256 0 0 0 0 16 7 8 45 35 23 101 21
2022/20231.030 136 54 79 71 84 45 10 108 186 107 127 23
2023/20241.076 71 109 211 81 38 169 80 44 29 19 94 131
2024/20251.378 37 7 12 16 16 165 78 91 248 319 176 213
2025/20263.756 574 224 182 350 145 198 1.046 199 233 218 167 220
2026/20271.531 296 251 644 293 47 0 0 0 0 0 0 0
Totale 9.703